BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Biotech Beach

  Rox Medical Inc. Raises $35 Million

  June 2, 2008

   · 

  1 min read
• Business

  ImClone Systems Incorporated Appoints Dr. Bernhard Ehmer Senior Vice President and Managing Director, International Operations

  June 2, 2008

   · 

  1 min read
• Biotech Beach

  Simulations Plus Releases Software Update for Better Pharmaceutical Drug Design

  June 2, 2008

   · 

  1 min read
• Drug Development

  Early Data Presented At American Society of Clinical Oncology Show Potential Of RAD001 To Enhance Efficacy Of, And Overcome Resistance To, Breast Cancer Treatments - Randomized Phase II Data Show RAD001 Significantly Increased Efficacy Of Letrozole Tablet

  June 2, 2008

   · 

  13 min read
• Drug Development

  BiPar Sciences, Inc. Presents Initial Clinical Data of BSI-201, a Novel DNA Repair Inhibitor - Phase I Trials Demonstrate Safety and Clinical Benefit in Monotherapy and Combination Therapy - - Data Presented at the 2008 American Society of Clinical Oncolo

  June 2, 2008

   · 

  2 min read
• Business

  Medtronic, Inc. Sees Earnings Growing 11-14 Pct Annually

  June 2, 2008

   · 

  1 min read
• Drug Development

  ANTISENSE PHARMA GmbH Release: Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements, Data Presented At 2008 American Society of Clinical Oncology Meeting

  June 2, 2008

   · 

  6 min read
• EU Agency Recommends Johnson & Johnson’s Anti-infective Doribax

  June 2, 2008

   · 

  1 min read
• Business

  Anthony Clarke, PhD Joins Alexza Pharmaceuticals, Inc. as Vice President, International Development Operations

  June 2, 2008

   · 

  3 min read
• Business

  Amira Pharmaceuticals, Inc. Achieves Milestones In FLAP Inhibitor Program With GlaxoSmithKline; GSK Exercises Option For AM803, A FLAP Inhibitor Which Recently Completed Phase I Studies

  June 2, 2008

   · 

  2 min read